To hear about similar clinical trials, please enter your email below
Trial Title:
HOme USability Evaluation
NCT ID:
NCT06134245
Condition:
Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Device
Intervention name:
Entia Liberty
Description:
Home monitoring
Summary:
To validate the usability and safety of the Liberty Analyser.
Criteria for eligibility:
Study pop:
Adults with a diagnosis of solid tumour cancer, who are currently undergoing systemic
anti-cancer therapy
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Undergoing systemic anti-cancer therapy (SACT)
- Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at
enrolment
- Adequate English language skills (not requiring a translator) to participate in
participant training and use the Entia Liberty analyser
- Patients capable of providing written informed consent
Exclusion Criteria:
- History or current diagnosis of haematological malignancy
- Patients with eyesight or hearing limitations or other disabilities that preclude
the use of the Entia Liberty analyser or participation in training
- Inadequate use and understanding of the English language, requiring a translator
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
March 1, 2024
Completion date:
June 30, 2024
Lead sponsor:
Agency:
Entia Ltd
Agency class:
Industry
Source:
Entia Ltd
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06134245
